Abbott Laboratories (NYSE:ABT) Receives FDA Approval For Coronary IVL System Trial In US [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Lithotripsy (IVL) System, a significant development within the realm of coronary artery disease treatment. This announcement comes in conjunction with the company's recent robust Q4 2024 earnings results, reporting net income and diluted EPS growth. Additionally, Abbott declared its 405th consecutive quarterly dividend and outlined optimistic sales growth projections for 2025. Despite broader market instability due to potential tariffs, Abbott's advancements have contributed to its 10% share price rise over the last quarter. Buy, Hold or Sell Abbott Laboratories? View our complete analysis and fair value estimate and you decide. Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart RhythmsPR Newswire
- Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart RhythmsPR Newswire
- In-vitro diagnostics market to grow at a CAGR of 5.1% (2024 – 2030): Wissen Research [Yahoo! Finance]Yahoo! Finance
- Abbott Hosts Conference Call for First-Quarter EarningsPR Newswire
- 2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/25 - In-Line
ABT
Sec Filings
- 3/14/25 - Form ARS
- 3/14/25 - Form DEFA14A
- 3/14/25 - Form DEF
- ABT's page on the SEC website